|
RNMT expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.820400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.346100E-02 |
| Normal-vs-Stage2 |
8.684800E-01 |
| Normal-vs-Stage3 |
1.131350E-01 |
| Normal-vs-Stage4 |
7.109800E-02 |
| Stage1-vs-Stage2 |
1.769990E-01 |
| Stage1-vs-Stage3 |
8.564400E-04 |
| Stage1-vs-Stage4 |
1.063040E-03 |
| Stage2-vs-Stage3 |
3.044800E-01 |
| Stage2-vs-Stage4 |
2.155400E-01 |
| Stage3-vs-Stage4 |
7.599800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.086200E-01 |
| Normal-vs-AfricanAmerican |
3.803000E-01 |
| Normal-vs-Asian |
9.539600E-01 |
| Caucasian-vs-AfricanAmerican |
3.206800E-01 |
| Caucasian-vs-Asian |
9.416000E-01 |
| AfricanAmerican-vs-Asian |
7.410000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.746800E-01 |
| Normal-vs-Female |
3.386800E-01 |
| Male-vs-Female |
7.357900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.608000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.495000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.868800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.063000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.840400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.182000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.936800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.321180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.313000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.060000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.083500E-03 |
| Normal-vs-Grade 2 |
4.048100E-02 |
| Normal-vs-Grade 3 |
1.767230E-01 |
| Normal-vs-Grade 4 |
4.160000E-03 |
| Grade 1-vs-Grade 2 |
2.175400E-01 |
| Grade 1-vs-Grade 3 |
4.939400E-03 |
| Grade 1-vs-Grade 4 |
2.974000E-04 |
| Grade 2-vs-Grade 3 |
1.350560E-04 |
| Grade 2-vs-Grade 4 |
8.4949000001E-07 |
| Grade 3-vs-Grade 4 |
5.307700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.982600E-03 |
| Normal-vs-ccB subtype |
2.691600E-01 |
| ccA subtype-vs-ccB subtype |
1.001840E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.081000E-01 |
| Normal-vs-N1 |
8.990200E-01 |
| N0-vs-N1 |
9.171800E-01 |
|
|
